Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07044531 · ClinicalTrials.gov registry record · NA

Development OF A Novel Peer Recovery Supporter Training Platform

A NA study of Substance Use Disorders and Alcohol Use Disorders, sponsored by Thrive Digital Health.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT07044531 is a NA study of Substance Use Disorders and Alcohol Use Disorders that is actively recruiting participants, run by Thrive Digital Health. The registered enrollment target is 120 participants, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07044531, a NA study of Substance Use Disorders and Alcohol Use Disorders, is actively recruiting participants, sponsored by Thrive Digital Health.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The focus of this study is to assess the effect on Peer Recovery Support Service providers of the fully asynchronous training platform (TDPP) and the TDPP with live zoom sessions on skill and adherence compared with training-as-usual.

Interventions

  • BEHAVIORAL Training-as-Usual (TAU)
  • BEHAVIORAL TDPP-A (Asynchronous Platform)
  • BEHAVIORAL TDPP-Z (Asynchronous + Zoom)

Study Locations (1)

Ohio

  • Thrive Digital Health - Solon

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-05-07
Est. Completion 2026-07
Phase NA

Sponsor

Thrive Digital Health

2 total trials

What the Registry Record Tells You About NCT07044531

The ClinicalTrials.gov registry entry for NCT07044531 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (76% lower). The listed sponsor is Thrive Digital Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 3 interventions - of which Training-as-Usual (TAU) is the first listed.

NCT07044531 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT07044531 about?

NCT07044531 is a clinical study titled "Development OF A Novel Peer Recovery Supporter Training Platform". The focus of this study is to assess the effect on Peer Recovery Support Service providers of the fully asynchronous training platform (TDPP) and the TDPP with live zoom sessions on skill and adherence compared with training-as-usual.

What is the current status of trial NCT07044531?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-05-07. Estimated completion is 2026-07.

What conditions does trial NCT07044531 study?

This clinical trial studies the following conditions: Substance Use Disorders, Alcohol Use Disorders, Recovery Support Services, Peer Recovery Coaching.

What interventions are being tested in trial NCT07044531?

The interventions under investigation include: Training-as-Usual (TAU) (BEHAVIORAL), TDPP-A (Asynchronous Platform) (BEHAVIORAL), TDPP-Z (Asynchronous + Zoom) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07044531?

This trial is sponsored by Thrive Digital Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07044531 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.